Development of Neurochemical Normalization (“Agonist Substitution”) Therapeutics for Stimulant Abuse: Focus on the Dopamine Uptake Inhibitor, GBR12909

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Iss. 1, 2004-03 ,pp. : 47-59

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence

By  

Current Pharmaceutical Design, Vol. 20, Iss. 13, 2014-04 ,pp. : 2089-2099

Bentham Science Publishers

Access to resources Recommend Favorite

The role of dopamine D₃ compared with D₂ receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats

By Millan Mark   Seguin Laetitia   Gobert Alain   Cussac Didier   Brocco Mauricette  

Psychopharmacology, Vol. 174, Iss. 3, 2004-07 ,pp. : 341-357

Springer Publishing Company

Access to resources Recommend Favorite

FAUC 213, a highly selective dopamine D₄ receptor full antagonist, exhibits atypical antipsychotic properties in behavioural and neurochemical models of schizophrenia

By Boeckler Frank   Russig Holger   Zhang Weining   Löber Stefan   Schetz John   Hübner Harald   Ferger Boris   Gmeiner Peter   Feldon Joram  

Psychopharmacology, Vol. 175, Iss. 1, 2004-08 ,pp. : 7-17

Springer Publishing Company

Access to resources Recommend Favorite

Behavioural evidence for cholecystokinin-dopamine D 1 receptor interactions in the rat

By Van Kampen J.   Frydryszak H.   Stoessl A.J.  

European Journal of Pharmacology, Vol. 298, Iss. 1, 1996-02 ,pp. : 7-15

Elsevier

Access to resources Recommend Favorite